Eli Lilly and Company
893 S Delaware St
Indianapolis
Indiana
46285
United States
About Eli Lilly and Company
Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.
Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly
3430 articles about Eli Lilly and Company
-
Lilly BioVentures Spins Out from Eli Lilly and Company (JOBS)
8/3/2009
-
Eli Lilly and Company Announces Continued Commitment to Transparency with Faculty Registry
7/31/2009
-
AutoImmune, Inc. Release: Clinical Trial by Licensee Does Not Meet Primary Endpoint
7/31/2009
-
Eli Lilly and Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
7/30/2009
-
454 Life Sciences and Roche NimbleGen, Inc Announce Collaboration with Eli Lilly and Company and SeqWright to Sequence Genomic Regions Associated with Psychiatric Disease
7/30/2009
-
Eli Lilly and Company (JOBS) and BioMS Medical Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
7/29/2009
-
Eli Lilly and Company to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
7/27/2009
-
Eli Lilly and Company Receives Award From National Medical Association
7/27/2009
-
Galapagos NV Achieves Milestone In Osteoporosis Collaboration With Eli Lilly and Company
7/23/2009
-
Eli Lilly and Company and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs; ImClone Systems Incorporated to Locate Resea
7/23/2009
-
Eli Lilly and Company Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
7/22/2009
-
Eli Lilly and Company (JOBS) 2nd-Quarter Profit Rises 21 Percent, Drugmaker Increases Full-Year Earnings Guidance
7/22/2009
-
Eli Lilly and Company ALIMTA(R) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer First Therapy Shown To Improve Overall Survival in Maintenance Setting in Patients with Nonsquamous NSCLC Histology
7/10/2009
-
FDA will Review Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes' Exenatide Application
7/8/2009
-
Eli Lilly and Company Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
7/7/2009
-
Eli Lilly and Company Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
7/6/2009
-
Eli Lilly and Company Declares Third-Quarter Dividend
6/23/2009
-
Akorn, Inc. Acquires Capastat(R) Sulfate from Eli Lilly and Company
6/17/2009
-
MacroGenics, Inc. and Eli Lilly and Company Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
6/16/2009
-
Eli Lilly and Company Announces New Drug Discovery Initiative
6/15/2009